Navigation Links
Quantitation of a Dinitro Flavonoid (DNF) in Rat Plasma Using the Varian 1200L LC/MS/MS System

D. Garteiz, R. Morrow, and B. Alexander, TexMS Analytical Services, Houston, TX C.
Schmidt, Varian, Inc., Walnut Creek, CA

Introduction

Flavonoids are compounds that make up the pigments in fruits, vegetables, and herbs. There have been reports of flavonoids having multiple beneficial therapeutic effects for a large number of serious illnesses, such as rheumatoid arthritis, cancer, cataracts, anxiety, and depression. The objective of this work was to carry out a pharmacokinetic evaluation to determine a profile with the formulation being tested at increasing doses where there is pharmacological effect.

A Varian 1200L LC/MS/MS system was used for the quantitation for plasma levels of a novel dinitro-substituted flavone (DNF) in samples from a pharmacokinetic study following oral administration of the drug. Flavone was used as the internal standard. Structures are shown in Figure 1.

Instrumentation

Varian 1200L LC/MS/MS equipped with ESI source

Materials and Reagents

DNF provided by Faber-Kramer Pharmaceuticals, Houston, Texas.

Flavone (Catalog Number F602) from Sigma-Aldrich.

All other chemicals are reagent grade or HPLC grade.

Sample Preparation

A 200 μL aliquot of rat plasma containing DNF is spiked with 10 μL of flavone (0.2 ng) as the internal standard (ISTD). The rat plasma is made basic and extracted with hexane: chloroform (2:1, v/v).

After separation of the phases by centrifugation, the organic layer is transferred by pouring into a silanized conical tube and evaporated to dryness. The dry residue is reconstituted in 50 μL of methanol:water (60:40, v/v).

A 10 μL aliquot is injected into an ESI-LC/MS/MS for analysis using Selected Reaction Monito ring (SRM).

Results and Discussion

The ratio of the area intensities of the product ion for DNF to the product ion of the internal standard [(m/z 221)/(m/z 129)] is used to calculate the DNF concentration in unknown rat plasma samples. The calibration curve is generated from the analysis of a drug-free rat plasma matrix fortified with various amounts of DNF and a fixed amount of the internal standard. The calibration curve range for DNF is from 0.10 ng/mL to 5.00 ng/mL of rat plasma.

Figure 2 shows the excellent response and peak shape obtained at the Lower Limit of Quantitation (LLOQ) and Upper Limit of Quantitation (ULOQ). Visual examination of the calibration curve in Figure 3 shows that good linearity was obtained with the linear-log, curve-fitting model used. Additional sensitivity can easily be obtained by increasing the sample volume used for the assay.

Conclusion

The pharmacokinetic plot derived from DNF plasma levels obtained with six rats is shown in Figure 4. Visual observation of the plot reveals that at three hours post-dose there is a drop in DNF concentration, which rebounds an hour later, and from that point the concentration drops gradually in a linear fashion.

This fluctuation in concentration may be due to a phenomenon known as entero-hepatic recirculation. Enterohepatic recirculation is a process defined as a recycling of a drug through the liver by its excretion in bile, followed by reabsorption of the drug from the intestines into the portal circulation and passage back to the liver, where it is reexcreted in the bile.

Another possibility to explain the fluctuation in concentration is related to the limited solubility of DNF in aqueous media. DNF may be precipitating in the stomach and then later moving into the intestines where its absorption takes place. More studies are n eeded to determine if either of the processes described above are in fact taking place.

From the results of this study, it can be concluded that pharmacokinetic studies using the rat will be useful for comparison of different DNF formulations and different modes of administration.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Quantitation of Cabergoline at Extremely Low Plasma Concentrations with a Triple Quadrupole Mass Spectrometer
2. Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine in Bovine Plasma using the TSQ Quantum Mass Spectrometer
3. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
4. Comparison of Different Methods of mRNA Quantitation
5. Quantitation of DNA for Automated Sequencing Using the VersaFluor Fluorometer
6. Quantitation of RNA for Hybridization Blots Using the VersaFluor Fluorometer
7. Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A
8. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
9. Benchmark Plus Microplate Reader: Quantitation of Protein Concentration Using Two Different Colorimetric Assay Kits, Rev A
10. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
11. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... , Feb. 17, 2017  If only one ... had a mutation-conferring resistance to chemotherapy, thousands of ... research has focused on finding these mutations in ... from circulating tumor DNA in blood — to ... therapeutics. Unfortunately, however, detecting these genetic ...
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent ... availability of a new report, Sensors for Robotics: Technologies, Markets ... ... ... IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine ...
Breaking Biology News(10 mins):